Edwards Lifesciences Corp (EW)
86.69
-0.73
(-0.84%)
USD |
NYSE |
May 10, 16:00
86.69
0.00 (0.00%)
After-Hours: 16:49
Edwards Lifesciences Cash from Financing (TTM): -442.70M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -442.70M |
December 31, 2023 | -711.00M |
September 30, 2023 | -1.136B |
June 30, 2023 | -1.063B |
March 31, 2023 | -1.423B |
December 31, 2022 | -1.584B |
September 30, 2022 | -808.10M |
June 30, 2022 | -699.20M |
March 31, 2022 | -450.10M |
December 31, 2021 | -356.30M |
September 30, 2021 | -252.90M |
June 30, 2021 | -257.90M |
March 31, 2021 | -174.80M |
December 31, 2020 | -486.90M |
September 30, 2020 | -491.30M |
June 30, 2020 | -490.90M |
March 31, 2020 | -746.40M |
December 31, 2019 | -115.60M |
September 30, 2019 | -997.30M |
June 30, 2019 | -1.088B |
March 31, 2019 | -1.098B |
December 31, 2018 | -1.101B |
September 30, 2018 | -485.50M |
June 30, 2018 | -408.50M |
March 31, 2018 | -41.00M |
Date | Value |
---|---|
December 31, 2017 | -473.20M |
September 30, 2017 | -239.10M |
June 30, 2017 | -195.60M |
March 31, 2017 | -290.70M |
December 31, 2016 | -268.50M |
September 30, 2016 | -333.30M |
June 30, 2016 | -373.50M |
March 31, 2016 | -455.80M |
December 31, 2015 | -158.60M |
September 30, 2015 | -53.00M |
June 30, 2015 | -27.90M |
March 31, 2015 | -81.10M |
December 31, 2014 | -153.00M |
September 30, 2014 | -118.40M |
June 30, 2014 | -98.50M |
March 31, 2014 | -84.00M |
December 31, 2013 | 34.90M |
September 30, 2013 | -192.50M |
June 30, 2013 | -261.60M |
March 31, 2013 | -177.40M |
December 31, 2012 | -155.60M |
September 30, 2012 | -62.30M |
June 30, 2012 | -159.00M |
March 31, 2012 | -197.80M |
December 31, 2011 | -135.20M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-1.584B
Minimum
Dec 2022
-115.60M
Maximum
Dec 2019
-688.82M
Average
-595.25M
Median
Cash from Financing (TTM) Benchmarks
Stryker Corp | -1.531B |
Align Technology Inc | -351.10M |
Abbott Laboratories | -6.857B |
Boston Scientific Corp | 1.643B |
Steris PLC | -133.36M |